Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (341-350 of 632) with videos related to

Pageof 64
Sort By:
Antiviral Therapy|October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trialMichael Manns, Henk Reesink, Thomas Berg, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infectionManfred Wiese, Janett Fischer, Micha Löbermann, et al.
Hepatology Communications|June 6, 2022
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-RegistryFrank Tacke, Hartwig Klinker, Klaus H W Boeker, et al.
Journal of Hepatology|September 15, 2020
Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis BMaria Pfefferkorn, Tina Schott, Stephan Böhm, et al.
Journal of Hepatology|July 19, 2022
Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinionGeorge V Papatheodoridis, Vasileios Lekakis, Thodoris Voulgaris, et al.
Scandinavian Journal of Gastroenterology|November 28, 2014
Noninvasive characterization of graft steatosis after liver transplantationThomas Karlas, Johanna Kollmeier, Stephan Böhm, et al.
Journal of Hepatology|March 22, 2017
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipientsLuca S Belli, Christophe Duvoux, Marina Berenguer, et al.
Plos One|June 14, 2018
Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosisSandra Krohn, Katharina Zeller, Stephan Böhm, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2019
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAsFrank Tacke, Klaus H W Boeker, Hartwig Klinker, et al.
Cancer|January 26, 2011
Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survivalTom Donnem, Kenneth Lonvik, Katrine Eklo, et al.
Pageof 64

Showing results (341-350 of 632) with videos related to

Sort By:
Pageof 64
Antiviral Therapy|October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trialMichael Manns, Henk Reesink, Thomas Berg, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infectionManfred Wiese, Janett Fischer, Micha Löbermann, et al.
Hepatology Communications|June 6, 2022
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-RegistryFrank Tacke, Hartwig Klinker, Klaus H W Boeker, et al.
Journal of Hepatology|September 15, 2020
Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis BMaria Pfefferkorn, Tina Schott, Stephan Böhm, et al.
Journal of Hepatology|July 19, 2022
Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinionGeorge V Papatheodoridis, Vasileios Lekakis, Thodoris Voulgaris, et al.
Scandinavian Journal of Gastroenterology|November 28, 2014
Noninvasive characterization of graft steatosis after liver transplantationThomas Karlas, Johanna Kollmeier, Stephan Böhm, et al.
Journal of Hepatology|March 22, 2017
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipientsLuca S Belli, Christophe Duvoux, Marina Berenguer, et al.
Plos One|June 14, 2018
Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosisSandra Krohn, Katharina Zeller, Stephan Böhm, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2019
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAsFrank Tacke, Klaus H W Boeker, Hartwig Klinker, et al.
Cancer|January 26, 2011
Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survivalTom Donnem, Kenneth Lonvik, Katrine Eklo, et al.
Pageof 64